1. Home
  2. BZH vs BCAX Comparison

BZH vs BCAX Comparison

Compare BZH & BCAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BZH
  • BCAX
  • Stock Information
  • Founded
  • BZH 1985
  • BCAX 2018
  • Country
  • BZH United States
  • BCAX United States
  • Employees
  • BZH N/A
  • BCAX N/A
  • Industry
  • BZH Homebuilding
  • BCAX
  • Sector
  • BZH Consumer Discretionary
  • BCAX
  • Exchange
  • BZH Nasdaq
  • BCAX NYSE
  • Market Cap
  • BZH 577.8M
  • BCAX 670.9M
  • IPO Year
  • BZH 1994
  • BCAX 2024
  • Fundamental
  • Price
  • BZH $18.59
  • BCAX $12.16
  • Analyst Decision
  • BZH Strong Buy
  • BCAX Buy
  • Analyst Count
  • BZH 3
  • BCAX 7
  • Target Price
  • BZH $39.67
  • BCAX $29.67
  • AVG Volume (30 Days)
  • BZH 418.0K
  • BCAX 516.6K
  • Earning Date
  • BZH 04-30-2025
  • BCAX 05-16-2025
  • Dividend Yield
  • BZH N/A
  • BCAX N/A
  • EPS Growth
  • BZH N/A
  • BCAX N/A
  • EPS
  • BZH 3.93
  • BCAX N/A
  • Revenue
  • BZH $2,412,332,000.00
  • BCAX N/A
  • Revenue This Year
  • BZH $12.48
  • BCAX N/A
  • Revenue Next Year
  • BZH $14.99
  • BCAX N/A
  • P/E Ratio
  • BZH $4.72
  • BCAX N/A
  • Revenue Growth
  • BZH 12.27
  • BCAX N/A
  • 52 Week Low
  • BZH $17.37
  • BCAX $8.91
  • 52 Week High
  • BZH $38.22
  • BCAX $28.09
  • Technical
  • Relative Strength Index (RSI)
  • BZH 40.46
  • BCAX N/A
  • Support Level
  • BZH $17.63
  • BCAX N/A
  • Resistance Level
  • BZH $18.87
  • BCAX N/A
  • Average True Range (ATR)
  • BZH 1.24
  • BCAX 0.00
  • MACD
  • BZH -0.05
  • BCAX 0.00
  • Stochastic Oscillator
  • BZH 33.89
  • BCAX 0.00

About BZH Beazer Homes USA Inc.

Beazer Homes USA Inc is an construction company that focuses on residential construction. The company specializes in single-family housing and multi-unit building construction in over 13 states and over 22 metro markets. Beazer Homes builds homes and communities that target first-time, move-up, and luxury homebuyers with an average selling price of roughly $300,000. From a geographic perspective, home sales in the western and eastern United States have been the leading sources of revenue for the company. Key metro areas include Atlanta, Las Vegas, Los Angeles, Orlando, and Tampa. The company also focuses on land purchasing and development to support future construction efforts as well as mortgage services for its homebuyers.

About BCAX BICARA THERAPEUTICS INC

Bicara Therapeutics Inc is a clinical-stage biopharmaceutical company bringing transformative bifunctional therapies to patients with solid tumors. Its program ficerafusp alfa is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor, or EGFR, directed monoclonal antibody with a domain that binds to human transforming growth factor beta, or TGF-b.

Share on Social Networks: